Navigation Links
2,500 Cases Completed With the Magnetic Irrigated Catheter

ST. LOUIS, Aug. 5 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS), announced today that clinicians have performed more than 2,500 procedures with the magnetic irrigated catheter since its commercial release. The clinical performance of the catheter in these cases has been exceptional. The major adverse cardiac event rate for magnetic procedures remains at 0.1%

"The irrigated tip is a great asset for creating deep lesions in patients with ventricular tachycardias in the setting of structural heart disease," said Dr. Raul Weiss, associate professor of medicine at The Ohio State University and an electrophysiologist at the Ross Heart Hospital in Columbus. "The Thermocool magnetic catheter creates deeper lesions because the catheter remains in contact with the beating heart. The irrigation allows me to deliver more energy, creating a larger lesion. You don't have to push on the catheter like you do with a manual catheter, so the likelihood of perforation, I think, is significantly reduced."

Overall, the Niobe Remote Magnetic Navigation System has been utilized in nearly 23,000 cases worldwide. These include ablations of a wide variety of cardiac arrhythmias in all four chambers of the heart and across a broad spectrum of patients ranging from pediatric to geriatric. Included in the Niobe clinical experience are several very compelling procedures in patients with congenital heart defects and patients with peripheral vascular occlusive disease. Altogether this represents the broadest range of cardiovascular applications achieved with any commercial remote magnetic, robotic or mechanical navigation system presently in the marketplace.

"The addition of the magnetic irrigated catheter has broadened the capabilities of the Stereotaxis system, further demonstrating the potential of our remote magnetic navigation technology as a platform for all manner of cardiac and vascular interventions," said Michael P. Kaminski, Stereotaxis President and CEO. "Stereotaxis labs are quickly becoming the preferred labs for complex cases at centers across the globe. These include a growing number of community hospitals, which are using our advanced technology to build robust electrophysiology practices. With the diverse group of clinicians who now routinely use our Niobe system, we are particularly delighted that the system has maintained the safety profile for which it has become well known."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe, and Canada and elsewhere.

About Forward Looking Statements

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance for the Company's products in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic and other filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. There can be no assurance that we will recognize revenue related to our purchase orders and other commitments in any particular period or at all because some of these purchase orders and other commitments are subject to contingencies that are outside of our control. In addition, these orders and commitments may be revised, modified or canceled, either by their express terms, as a result of negotiations, or by project changes or delays.

SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
2. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
3. Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
4. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
5. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
6. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
7. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
8. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
9. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
10. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
11. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
Post Your Comments:
(Date:11/24/2015)... Va. , Nov. 24, 2015  DILON Diagnostics ... have signed an agreement for DILON to distribute GE,s ... across the globe. The signing of this distribution agreement will ... NM750b Molecular Breast Imaging system and is considered an ... provide better healthcare solutions for clinicians and their patients. ...
(Date:11/24/2015)... 2015 . ... adds Latest Guidebook for Chinese Medical Device GMP ... in November 2015 to the medical devices market ... at . China ... global economies with a fifth population in the ...
(Date:11/24/2015)... , Nov. 24, 2015  Figure 1, a free ... share medical cases, has launched a new completely redesigned ... web version allows radiologists, who work primarily on a ... further engage with its radiologist user base, Figure 1 ... North America (RSNA) Annual Meeting. ...
Breaking Medicine Technology:
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... DMG Productions ... Ed Begley Jr., airing first quarter 2016 via Discovery Channel. Dates and show times ... the Province, and is in the business of producing and supplying medical marijuana pursuant ...
(Date:11/24/2015)... ... November 24, 2015 , ... It takes only three to five seconds to ... that the first impression be positive and reflects business values. If a client starts ... or want to return. They will also share their thoughts about a business with ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... 2015 , ... The American Association of Poison Control Centers ... through donations on Tuesday, Dec. 1, 2015. Since 2012, the Tuesday following Thanksgiving ... to collaborate in improving their local communities and help give back in impactful ...
(Date:11/24/2015)... ... 24, 2015 , ... With Thanksgiving right around the corner, holiday travel season ... protect your family and vehicle. , According to the National Highway Traffic Safety Administration, ... is sharing the following safety tips from the NHTSA: , ...
Breaking Medicine News(10 mins):